Technology | November 29, 2007

Bayer Opens New Door to Contrast Media Safety

Bayer Healthcare Pharmaceuticals responded to concerns by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) on administering contrast agents by previewing at RSNA 2007 VistaTrak, a password protected contrast media cabinet that tracks media stock using RFID labels.

Designed to help meet JCAHO regulations on safety, the cabinet can be interfaced with an electronic medical record (EMR), PACS/RIS and billing system to access patient data and monitor for allergic reactions. The monitoring system is designed to help prevent the potential risk of nephrogenic systemic fibrosis (NSF) when a patient is injected with gadolinium-containing contrast agents for magnetic resonance imaging (MRI). The company’s MAGNEVIST (gadopentetate dimeglumine) contrast agent will be the first product to carry the RFID tag in the VistaTrak cabinet.

The cabinet is also password protected to comply with JCAHO’s requirement for contrast agent cabinets to be kept under lock and key. The cabinet is only accessible by using either a coded badge or a pin code.

Once a bottle is removed, the RFID tag inside of the cabinet reads the lot number, expiration date and other information on the label required by JCAHO. The EMR, PACS/RIS and billing system are updated when a bottle is removed from the cabinet to track the procedure and inventory. VistaTrak will not be commercially available until mid-2008.

November 2007

Related Content

ITN Wins Jesse H. Neal Award for Best Technical Content
News | Radiology Business | April 24, 2019
April 24, 2019 — Imaging Technology News (ITN) was recently named the 2019 Jesse H.
Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Feature | Contrast Media Injectors | April 11, 2019 | By Jeff Zagoudis
One of the most controversial issues in radiology in recent years has been the use of...
GU12171120

GU12171120

Sponsored Content | Case Study | Contrast Media Injectors | April 02, 2019
The continuing search for advantages to improve workflow has radiology departments constantly searching for new solut
Non-Contrast MRI Effective in Monitoring MS Patients
News | Neuro Imaging | March 18, 2019
Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach...
Ultrasound Societies Urge FDA to Remove "Black Box" on Ultrasound Contrast Agents
News | Ultrasound Imaging | March 07, 2019
National and international ultrasound societies are urging the U.S. Food and Drug Administration to remove the “black...
Sponsored Content | Case Study | Contrast Media | January 30, 2019
The medical imaging market relies heavily on contrast media, injected into patients to increase the contrast of bodil
Sponsored Content | Videos | Contrast Media | January 22, 2019
ITN Contributing Editor Greg Freiherr speaks with Guerb
Videos | Artificial Intelligence | December 21, 2018
Enhao Gong, Ph.D., founder of Subtle Medical, an artificial intelligence (AI) company that develops products to help
Guerbet Showcases Diagnostic and Interventional Imaging Solutions at RSNA 2018
News | Interventional Radiology | December 12, 2018
Guerbet LLC USA highlighted new and next-level product offerings and partnerships in contrast media, injectors,...
Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...